NSE
Bliss GVS Pharma LimitedBLISSGVS
Bliss GVS Pharma Limited is a pharmaceutical company engaged in the manufacture, marketing, and distribution of pharmaceuticals. It is listed on the National Stock Exchange (NSE) under the ticker BLISSGVS.
| Key products | Antibiotics, Pain relief medications |
|---|---|
| Geography | India, International markets |
| Competitors | Sun Pharma, Cipla Ltd. |
AI-generated overview — verify before relying on it.
Net institutional flow
−₹150 Cr
Institutional buyers
1 in / 2 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹2.9 Cr | 96 | — | — | — | — |
| 2 | BLISSGVSThis | +₹0 Cr | 3 | — | — | — | — |
| 3 | MOBIKWIK | +₹0 Cr | 12 | — | — | — | — |
| 4 | QUADFUTURE | +₹0 Cr | 34 | — | — | — | — |
| 5 | IRMENERGY | — | — | — | — | — | — |
| 6 | MTNL | — | — | — | — | — | — |
| 7 | GATECH | — | — | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Strengths
- • [object Object]
- • [object Object]
Weaknesses
- • [object Object]
- • [object Object]
Opportunities
- • [object Object]
- • [object Object]
Threats
- • [object Object]
- • [object Object]
AI-generated from our data — verify before relying on it.
- 2026-06-11FilingBliss GVS Pharma Limited has informed the Exchange regarding allotment of 267250 securities pursuant to ESOP/EAllotment of Securities
- 2026-06-09FilingBliss GVS Pharma Limited has informed the Exchange about Submission Of Draft Letter Of Offer In Relation To ThShareholding Disclosure
- 2026-05-29BulkBUY · ₹19.2 CrHRTI PRIVATE LIMITED
- 2026-05-29BulkSELL · ₹23.7 CrHRTI PRIVATE LIMITED
- 2026-05-29NetDay net −₹4.5 Cr
- 2026-05-25BulkSELL · ₹32 CrSHAILESH SHIVKUMAR DALMIA
- 2026-05-25NetDay net −₹32 Cr
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2Allotment of SecuritiesNeutral
allotment of 267250 securities pursuant to ESOP/ESPS at its meeting held on Jun 11, 2026
Source PDF → - 2Shareholding DisclosureNeutral
Submission Of Draft Letter Of Offer In Relation To The Open Offer Made To The Public Shareholders Of Bliss GVS Pharma Limited Under The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Source PDF →
3 deals · 2026-05-25 → 2026-05-29
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2026-05-29 | HRTI PRIVATE LIMITED | Prop / churn | BUY | ₹19.2 Cr |
| 2026-05-29 | HRTI PRIVATE LIMITED | Prop / churn | SELL | ₹23.7 Cr |
| 2026-05-25 | SHAILESH SHIVKUMAR DALMIA | HNI / other | SELL | ₹32 Cr |
3 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
Financial results
None yet.
News & chatter on BLISSGVS
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.